sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
Dermatology Drugs Market [(By Therapeutic Area (Atopic Dermatitis, Psoriasis, Acne, Rosacea), By Marketed Therapies (Biologics, Oral Drugs, Topical Drugs), By Approved Treatments (etanercept (Enbrel), infliximab (Remicade), adalimumab (Humira), ustekinumab (Stelara), secukinumab (Cosentyx), ixekizumab (Taltz), golimumab (Simponi), brodalumab (Siliq), and guselkamab (Tremfya), and By Region]: Market Size & Forecast, 2017 - 2022

Dermatology Drugs Market [(By Therapeutic Area (Atopic Dermatitis, Psoriasis, Acne,...

Home / Categories / Healthcare
Dermatology Drugs Market [(By Therapeutic Area (Atopic Dermatitis, Psoriasis, Acne, Rosacea), By Marketed Therapies (Biologics, Oral Drugs, Topical Drugs), By Approved Treatments (etanercept (Enbrel), infliximab (Remicade), adalimumab (Humira), ustekinumab (Stelara), secukinumab (Cosentyx), ixekizumab (Taltz), golimumab (Simponi), brodalumab (Siliq), and guselkamab (Tremfya), and By Region]: Market Size & Forecast, 2017 - 2022
Dermatology Drugs Market [(By Therapeutic...
Report Code
RO1/107/1018

Publish Date
01/Feb/2018

Pages
75
PRICE
$ 1800/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 2350/-
This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF.
$ 2850/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..

Table of Contents
1. Dermatology Overview
2. Key Indications in Dermatology Drugs Market Therapy Area
2.1. Atopic Dermatitis Overview
2.2. Psoriasis Overview
2.3. Acne Overview
2.4. Rosacea Overview
3. Diagnosis Patterns
4. Dermatology- Fragmented Market with Several Opportunities
5. Epidemiology-Prevalent Population & Segmentations
5.1. Atopic Dermatitis-Prevalent Population (2016-2022)
5.2. Psoriasis-Prevalent Population (2016-2022)
5.3. Acne-Prevalent Population (2016-2022)
5.4. Rosacea-Prevalent Population (2016-2022)
6. Treatment Patterns and Treatment Algorithms in Dermatology Therapeutic Area
6.1. Atopic Dermatitis-Treatment Practices
6.2. Psoriasis-Treatment Practices
6.3. Acne-Prevalent Treatment Practices
6.4. Rosacea-Treatment Practices
7. Market Forecast by Therapeutic Area (2016-2022)
7.1. Atopic Dermatitis- Market Forecast (2016-2022)
7.2. Psoriasis- Market Forecast (2016-2022)
7.3. Acne- Market Forecast (2016-2022)
7.4. Rosacea- Market Forecast (2016-2022)
8. Marketed Drugs and Sales Forecast (2016-2022)
8.1. Atopic Dermatitis Key Drugs Market Forecast
8.1.1. dupilumab (Dupixent)-Sanofi-Sales forecast 2016-2022
8.1.2. Nemolizumab-Galderma-Sales forecast 2016-2022
8.1.3. Tralokinumab- LEO Pharma-Sales forecast 2016-2022
8.1.4. Crisaborole (Eucrisa)-Pfizer-Sales forecast 2016-2022
8.1.5. RVT-501-Roviant Sciences-Sales forecast 2016-2022
8.1.6. OPA-15406- Otsuka Pharmaceuticals-Sales forecast 2016-2022
8.2. Psoriasis Key Drugs Market Forecast
8.2.1. etanercept; Enbrel-Sales forecast 2016-2022
8.2.2. infliximab; Remicade-Sales forecast 2016-2022
8.2.3. adalimumab; Humira-Sales forecast 2016-2022
8.2.4. ustekinumab; Stelara-Sales forecast 2016-2022
8.2.5. secukinumab; Cosentyx-Sales forecast 2016-2022
8.2.6. ixekizumab; Taltz-Sales forecast 2016-2022
8.2.7. golimumab; Simponi-Sales forecast 2016-2022
8.2.8. brodalumab; Siliq-Sales forecast 2016-2022
8.2.9. guselkamab; Tremfya-Sales forecast 2016-2022
8.3. Acne Key Drugs Market Forecast
8.3.1. Acne Topical Drugs Market Sales & Share 2016-2022
8.3.2. Acne Oral Drugs Market Sales & Share 2016-2022
8.4. Rosacea Key Drugs Market Forecast
8.4.1. Acne Topical Drugs Market Sales & Share 2016-2022
8.4.2. Acne Oral Antibiotics Market Sales & Share 2016-2022
9. Market Forecast by Regions (2016-2022)
9.1. North America- Market Forecast (2016-2022)
9.2. Europe- Market Forecast (2016-2022)
9.3. APAC-Market Forecast (2016-2022)
9.4. ROW- Market Forecast (2016-2022)
10. Factors Driving the Market of Dermatology Drugs
11. Factors Restraining the Market of Dermatology Drugs
12. About Polaris Market Research
13. Disclaimer
14. Sales Support

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com